Evidence map›Paper›PMID 38624681›Full record

ArticleSmall business economics2022

Small firms and the COVID-19 insolvency gap.

Julian Oliver Dörr, Georg Licht, Simona Murmann

Abstract read
In one paragraph

Article in Small business economics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Competition and firm recovery post-COVID-19.Small business economics · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Socio-Ecological Factors and Well-Being among Self-Employed in Europe during the COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julian Oliver DörrDepartment of Economics of Innovation and Industrial Dynamics, ZEW Leibniz Centre for European Economic Research, L7 1, 68161 Mannheim, Germany.ORCID 0000-0002-6465-181X
Georg LichtDepartment of Economics of Innovation and Industrial Dynamics, ZEW Leibniz Centre for European Economic Research, L7 1, 68161 Mannheim, Germany.
Simona MurmannDepartment of Economics of Innovation and Industrial Dynamics, ZEW Leibniz Centre for European Economic Research, L7 1, 68161 Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 placed a special role on fiscal policy in rescuing companies short of liquidity from insolvency. In the first months of the crisis, SMEs as the backbone of Germany's economy benefited from large and mainly indiscriminate aid measures. Avoiding business failures in a whatever-it-takes fashion contrasts, however, with the cleansing mechanism of economic crises: a mechanism which forces unviable firms out of the market, thereby reallocating resources efficiently. By focusing on firms' pre-crisis financial standing, we estimate the extent to which the policy response induced an insolvency gap and analyze whether the gap is characterized by firms which were already struggling before the pandemic. With the policy measures being focused on smaller firms, we also examine whether this insolvency gap differs with respect to firm size. Our results show that the COVID-19 policy response in Germany has triggered a backlog of insolvencies that is particularly pronounced among financially weak, small firms, having potential long-term implications on entrepreneurship and economic recovery.

Indexed as

Cleansing effectCorporate insolvencyCOVID-19EntrepreneurshipInsolvency lawLiquidity supportSMEs

Identifiers

PMID38624681
PMCPMC8258278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.